MedinCell S.A. | MEDCL Logo | Annual Report & Investor Relations Data

MedinCell S.A. | MEDCL Annual Report & Investor Relations Data

ISIN

FR0004065605

Ticker

MEDCL

Sector

Health Care

Industry

Biotechnology

Country

France

Year Founded

2003

MedinCell S.A. (MEDCL)
Company Overview & Profile

Company Description

MedinCell® is a pharmaceutical company at premarketing stage that develops innovative long-acting injectable medicines in many therapeutic areas. Products of our portfolio are based on our BEPO® technology and aim to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier one pharmaceuticals companies and foundations to improve Global Health through new therapeutic options.

Headcount

147

Served Area

Worldwide

Headquarters

3 Rue des Frères Lumière
34380, Jacou
France

MedinCell S.A. (MEDCL)
Filings & Annual Reports

Filters

View all types
Type Document Details Language Filing Date File Number

Get API Access

Access comprehensive European stock market filings data through a single, powerful API.

1,5M+

filings covered

18

European countries

30min

max latency

1 API

for all filings

MedinCell S.A. (MEDCL)
Insider Trading Activity

Date Trading entity / Person Association Trade type Volume
02.05.2023 None Other Sell EUR 600,006.00

MedinCell S.A. (MEDCL)
Leadership: Management & Supervisory Board

No Leadership Information Available

We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.

MedinCell S.A. (MEDCL)
Stock & Investor Information

ISIN

FR0004065605

LEI

969500R79U6PXCL2FF46

Stock Exchange Listings

Euronext Paris

Primary Stock Exchange Listing

View MedinCell S.A. on main stock exchange

Industry Classification

MedinCell S.A. (MEDCL)
Related Companies & Peer Group

4SC AG Logo

4SC AG

VSC

Sector

Health Care

Country

Germany

ISIN

DE000A3E5C40

Founded

1997

4SC focuses on the development of novel small molecule drugs that target key mechanisms of cancer development, such as histone …

ABIONYX Pharma Logo

ABIONYX Pharma

ABNX

Sector

Health Care

Country

France

ISIN

FR0012616852

Founded

ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there …

Abliva Logo

Abliva

ABLI

Sector

Health Care

Country

Sweden

ISIN

SE0002575340

Founded

2000

Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when …

AB Science Logo

AB Science

AB

Sector

Health Care

Country

France

ISIN

FR0010557264

Founded

2001

AB Science is a late-clinical-stage French company founded in 2001 by a team of scientists with the goal of developing …

Acticor Biotech Logo

Acticor Biotech

ALACT

Sector

Health Care

Country

France

ISIN

FR0014005OJ5

Founded

Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of …

Active Biotech Logo

Active Biotech

ACTI

Sector

Health Care

Country

Sweden

ISIN

SE0001137985

Founded

1998

Active Biotech develops pharmaceutical products within medical areas where the immune system is of significant importance, including cancer and inflammatory …